Related Experiment Video
Updated: Jun 4, 2026
07:10
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Open- and closed-loop multiobjective optimal strategies for HIV therapy using NSGA-II.
S Mostapha Kalami Heris1, Hamid Khaloozadeh
1Control Engineering Department, Faculty of Electrical and Computer Engineering, K N Toosi University of Technology, Tehran, Iran. kalami@ieee.org
IEEE Transactions on Bio-Medical Engineering
|February 8, 2011
Summary
This study presents optimal HIV/AIDS treatment strategies using multiobjective optimization. It compares open- and closed-loop control methods to balance drug usage and treatment quality for personalized patient care.
Area of Science:
- * Mathematical modeling and optimization applied to infectious disease treatment.
- * Computational biology and control theory in public health.
Background:
- * Highly active antiretroviral therapy (HAART) is the standard for managing HIV infection.
- * Optimizing HIV treatment requires balancing drug dosage, treatment efficacy, and patient adherence.
- * Existing treatment strategies may not account for individual patient variability or real-time feedback.
Purpose of the Study:
- * To develop and compare multiobjective, open- and closed-loop optimal treatment strategies for HIV/AIDS.
- * To identify treatment plans that optimize both drug usage and treatment quality.
- * To analyze the robustness of closed-loop strategies under noisy measurements.
Main Methods:
- * Formulation of a biobjective optimization problem with drug usage and treatment quality as objectives.
- * Application of Nondominated Sorting Genetic Algorithm II (NSGA-II) for solving the optimization problem.
- * Implementation and comparison of open-loop and closed-loop control strategies.
- * Analysis of closed-loop system robustness against varying levels of measurement noise.
Main Results:
- * Generation of Pareto frontiers representing sets of optimal treatment strategies.
- * Demonstration that Pareto frontiers offer diverse options for varying medical and economic conditions.
- * Identification of trade-offs between drug dosage and treatment quality across different strategies.
- * Validation of closed-loop control robustness in simulated noisy environments.
Conclusions:
- * Multiobjective optimization provides a framework for personalized HIV/AIDS treatment strategies.
- * Open- and closed-loop strategies offer distinct advantages in managing HIV infection.
- * The Pareto frontier aids clinicians in selecting optimal treatments based on specific patient needs and resource availability.
- * Closed-loop control shows promise for adaptive HIV treatment, even with imperfect real-time data.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:24Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
01:23Dosage Regimen Designs: Nomograms and Tabulations
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...